Differential expression of the HLA-DR genes in various melanoma cell lines treated with interferon-γ: Methylation of the HLA-DRα gene in these lines is not correlated with its expression

[1]  M. Herlyn,et al.  Recombinant gamma-interferon induces changes in expression and shedding of antigens associated with normal human melanocytes, nevus cells, and primary and metastatic melanoma cells. , 1985, Journal of immunology.

[2]  M. Capobianchi,et al.  Differences in the expression and release of DR, BR, and DQ molecules in human cells treated with recombinant interferon gamma: comparison to other interferons. , 1985, Human immunology.

[3]  A. Houghton,et al.  Surface antigens of melanoma and melanocytes. Specificity of induction of Ia antigens by human gamma-interferon , 1984, Journal of Experimental Medicine.

[4]  M. Pollack,et al.  Functional characteristics and differential expression of class II DR, DS, and SB antigens on human melanoma cell lines. , 1984, Human immunology.

[5]  D. Hatat,et al.  Differential regulation of HLA‐DR mRNAs and cell surface antigens by interferon. , 1983, The EMBO journal.

[6]  S. Weissman,et al.  Structure and nucleotide sequence of the heavy chain gene of HLA-DR. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[7]  T. Merigan,et al.  Recombinant interferon-gamma increases HLA-DR synthesis and expression. , 1983, Journal of immunology.

[8]  J. Cairncross,et al.  Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets , 1982, The Journal of experimental medicine.

[9]  B. White,et al.  Cytoplasmic dot hybridization. Simple analysis of relative mRNA levels in multiple small cell or tissue samples. , 1982, The Journal of biological chemistry.

[10]  T. Merigan,et al.  Interferon increases HLA synthesis in melanoma cells: interferon-resistant and -sensitive cell lines. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Strominger,et al.  Analysis of HLA-DR antigens by using monoclonal antibodies: recognition of conformational differences in biosynthetic intermediates. , 1981, Journal of immunology.

[12]  R. Palmiter,et al.  DNA methylation controls the inducibility of the mouse metallothionein-I gene in lymphoid cells , 1981, Cell.

[13]  W. Clark,et al.  Specific immunoreactivity of hybridoma-secreted monoclonal anti-melanoma antibodies to cultured cells and freshly derived human cells. , 1980, Cancer research.

[14]  H. Cedar,et al.  Reconstitution of a deoxyribonuclease I-sensitive structure on active genes. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[15]  P Chambon,et al.  DNA methylation: organ specific variations in the methylation pattern within and around ovalbumin and other chicken genes. , 1979, Nucleic acids research.

[16]  J. McGhee,et al.  Specific DNA methylation sites in the vicinity of the chicken β-globin genes , 1979, Nature.

[17]  Arthur Bank,et al.  Organization of human δ- and β-globin genes in cellular DNA and the presence of intragenic inserts , 1978, Cell.

[18]  C. Barnstable,et al.  Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis , 1978, Cell.

[19]  C. Milstein,et al.  Fusion between immunoglobulin‐secreting and nonsecreting myeloma cell lines , 1976, European journal of immunology.

[20]  Arthur D. Riggs,et al.  X inactivation, differentiation, and DNA methylation. , 1975, Cytogenetics and cell genetics.

[21]  Adams Ra.  Formal discussion: the role of transplantation in the experimental investigation of human leukemia and lymphoma. , 1967 .